Multimodal ultrasonographic and clinicopathological model for predicting high-volume lymph node metastasis in cN0 papillary thyroid carcinoma
- Jiwen Qian 1, Zheng Zhang 1, Yanwei Chen 1, Shuangshuang Zhao 1, Wenjun Li 1, Jiayan Bao 1, Huajiao Zhao 1, Yun Cai 1, Baoding Chen 1
- Jiwen Qian 1, Zheng Zhang 1, Yanwei Chen 1
- 1Department of Medical Ultrasound, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
- 0Department of Medical Ultrasound, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new predictive model accurately identifies high-volume lymph node metastasis (HVLNM) in papillary thyroid cancer (PTC) patients. This tool aids clinicians in personalizing treatment and reducing reoperations.
Area Of Science
- Oncology
- Radiology
- Genetics
Background
- Preoperative diagnosis of high-volume lymph node metastasis (HVLNM) in clinically lymph node-negative (cN0) papillary thyroid carcinoma (PTC) presents a significant clinical challenge.
- Accurate prediction of HVLNM is crucial for effective treatment planning and reducing unnecessary interventions.
Purpose Of The Study
- To construct and validate a comprehensive predictive model for HVLNM in cN0 PTC.
- To integrate conventional ultrasound, contrast-enhanced ultrasound (CEUS), BRAF<sup>V600E</sup> mutation status, and clinicopathological data into a predictive tool.
Main Methods
- A retrospective study included 126 cN0 PTC patients for training and 47 for external validation.
- Univariate and multivariate analyses identified independent predictors.
- A binary logistic regression model and nomogram were developed and validated using cross-validation, calibration curves, and decision curve analysis (DCA).
Main Results
- Age, Dmax, ACR scores ≥11, and heterogeneous enhancement were identified as independent predictors of HVLNM.
- The nomogram achieved an Area Under the Curve (AUC) of 0.860 in the training set and 0.885 in the external validation set.
- The model demonstrated robust calibration and clinical utility via DCA.
Conclusions
- The developed nomogram is a simple, cost-effective tool for predicting HVLNM in cN0 PTC.
- This visualization tool assists clinicians in formulating personalized treatment strategies and potentially lowering reoperation rates.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

